MaxsMaking Inc. Reports Fiscal Year 2025 Financial Results
Mr.
"In the highly competitive domestic market, we strengthened our sales initiatives to expand our customer base. We implemented a volume-driven strategy supported by penetration pricing and new customer acquisition through relationship-based referrals. These efforts contributed to a 36.33% year-over-year increase in revenue. Importantly, this growth helped offset the temporary slowdown in our overseas business and broadened and diversified our future customer base.
"At the same time, we remained committed to innovation, increasing our research and development ("R&D") spending by 16.38%. This investment reflects our long-term focus on product enhancement and on building sustainable differentiation in the customized consumer goods market.
"Although our profits and margins were temporarily affected by the volume-driven strategy, we believe our business model remains resilient and scalable. Today, we operate with a more diversified market presence, a broader customer base, and an expanding product portfolio. We believe all of these will support our future growth.
"It is also worth noting that our initial public offering (the "IPO") on the Nasdaq in
"Looking ahead, we believe our strategy and execution will provide a foundation for long-term value. As current disruptions and uncertainties evolve, we expect to continue adapting to market conditions and pursuing growth opportunities as they arise."
Fiscal Year 2025 Financial Summary
- Revenue was
$29.22 million in fiscal year 2025, representing an increase of 36.33% compared to$21.43 million in fiscal year 2024. - Gross profit was
$2 .62 million in fiscal year 2025, compared to$3.97 million in fiscal year 2024. - Gross profit margin was 8.95% in fiscal year 2025, compared to 18.52% in fiscal year 2024.
- Net income was
$0 .02 million in fiscal year 2025, compared to$1.88 million in fiscal year 2024. - Basic and diluted earnings per A share and B share were
$0 .00 in fiscal year 2025, compared to$0 .25 in fiscal year 2024.
Fiscal Year 2025 Financial Results
Revenue
Revenue was
For the Fiscal Year | For the Fiscal Year | Change | |||||||||||||||||
Country/Region | Sales | As % of | Sales | As % of | Amount | % | |||||||||||||
Mainland | $ | 26,643,100 | 91.18 | % | $ | 17,285,726 | 80.65 | % | $ | 9,357,374 | 54.13 | % | |||||||
| 810,415 | 2.77 | % | 1,998,048 | 9.32 | % | (1,187,633) | (59.44) | % | ||||||||||
345,277 | 1.18 | % | 276,746 | 1.29 | % | 68,530 | 24.76 | % | |||||||||||
1,266,824 | 4.34 | % | 1,806,989 | 8.43 | % | (540,165) | (29.89) | % | |||||||||||
41,158 | 0.14 | % | 16,650 | 0.08 | % | 24,508 | 147.19 | % | |||||||||||
62,948 | 0.22 | % | 30,170 | 0.14 | % | 32,778 | 108.64 | % | |||||||||||
51,124 | 0.17 | % | 19,771 | 0.09 | % | 31,354 | 158.59 | % | |||||||||||
Total | 29,220,846 | 100.00 | % | $ | 21,434,100 | 100.00 | % | $ | 7,786,746 | 36.33 | % | ||||||||
Cost of Revenue
Cost of revenue was
Gross Profit and Gross Profit Margin
Gross profit was
Gross profit margin was 8.95% in fiscal year 2025, compared to 18.52% in fiscal year 2024. The decline in gross profit margin was primarily attributable to a decrease in overseas sales, which historically generate higher margins. As overseas sales declined, the Company's overall gross profit decreased. In response, the Company intensified its sales efforts in the domestic market and adopted a lower-price, higher-volume strategy, which increased domestic sales but carried a lower margin and further compressed the Company's overall gross profit margin.
Operating Expenses
Operating expenses were
- Selling expenses were
$0.46 million in fiscal year 2025, representing a decrease of 23.76% from$0.61 million in fiscal year 2024. The decrease was mainly due to lower salary expenses resulting from a reduction in headcount, and a decrease in freight expenses. - General and administrative expenses were
$1.40 million in fiscal year 2025, representing an increase of 132.97% from$0.60 million in fiscal year 2024. The increase was mainly due to (i) an increase in accounts receivable allowance of approximately$0.17 million ; and (ii) an increase in professional fees of$0.44 million in connection with the Company's IPO inJuly 2025 . - Research and development expenses were
$0.65 million in fiscal year 2025, representing an increase of 16.38% from$0.56 million in fiscal year 2024. The increase was primarily attributable to an increase in salaries of the Company's R&D personnel.
Net Income
Net income was
Basic and Diluted Earnings per Share
Basic and diluted earnings per A share and B share were
Financial Condition
As of
Net cash used in operating activities was
Net cash used in investing activities was
Net cash provided by financing activities was
About MaxsMaking Inc.
Founded in 2007 and headquartered in
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as "approximates," "believes," "hopes," "expects," "anticipates," "estimates," "projects," "intends," "plans," "will," "would," "should," "could," "may" or other similar expressions in this announcement. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's annual report on Form 20-F for the fiscal year ended
For more information, please contact:
MaxsMaking Inc.
Investor Relations
Email: [email protected]
Ascent Investor Relations LLC
Phone: +1-646-932-7242
Email: [email protected]
MAXSMAKING INC. | |||||||
CONSOLIDATED BALANCE SHEETS | |||||||
FOR THE FISCAL YEARS ENDED | |||||||
IN U.S. DOLLARS, EXCEPT SHARE DATA | |||||||
|
| ||||||
ASSETS | |||||||
Current Assets | |||||||
Cash | $ | 122,381 | $ | 176,236 | |||
Accounts receivable, net | 9,877,030 | 6,188,992 | |||||
Due from related parties | 36,815 | — | |||||
Inventories | 6,504,761 | 2,633,615 | |||||
Other receivables and other current assets | 5,003,667 | 7,452,317 | |||||
Total current assets | 21,544,654 | 16,451,160 | |||||
Non-Current Assets | |||||||
Plant and equipment, net | 153,271 | 119,125 | |||||
Intangible assets, net | 6,447 | 7,433 | |||||
Right-of-use assets, net | 71,482 | 86,441 | |||||
Deferred tax assets | 66,383 | 24,538 | |||||
Deferred offering cost | - | 986,206 | |||||
Total non-current assets | 297,583 | 1,223,743 | |||||
Total Assets | $ | 21,842,237 | $ | 17,674,903 | |||
LIABILITIES AND EQUITY | |||||||
Current Liabilities | |||||||
Short-term loans | $ | 1,954,007 | $ | 2,785,965 | |||
Accounts payable | 3,243,451 | 2,127,623 | |||||
Contract liability | 449,306 | 512,859 | |||||
Income tax payable | 952,041 | 859,194 | |||||
Other payables and accrued liabilities | 259,345 | 867,249 | |||||
Due to related parties | - | 149,757 | |||||
Lease liabilities-current | 13,145 | 47,895 | |||||
Current portion of long-term loan | 22,573 | - | |||||
Total current liabilities | 6,893,868 | 7,350,542 | |||||
Non-Current Liabilities | |||||||
Lease liabilities-non current | 57,841 | — | |||||
Non-current portion of long-term loans | 2,278,162 | 2,058,651 | |||||
Total non-current liabilities | 2,336,003 | 2,058,651 | |||||
Total liabilities | 9,229,871 | 9,409,193 | |||||
COMMITMENTS AND CONTINGENCIES (NOTE 17) | |||||||
Equity | |||||||
A Shares ( | 92,000 | 75,750 | |||||
B Shares ( | 74,250 | 74,250 | |||||
Additional paid-in capital | 5,972,110 | 1,712,492 | |||||
Statutory surplus reserve | 788,123 | 705,396 | |||||
Retained earnings | 5,726,180 | 5,806,881 | |||||
Accumulated other comprehensive loss | (368,876) | (421,542) | |||||
Total MaxsMaking Inc.'s Equity | 12,283,787 | 7,953,227 | |||||
Non-Controlling Interests | 328,579 | 312,483 | |||||
Total equity | 12,612,366 | 8,265,710 | |||||
Total Liabilities and Equity | $ | 21,842,237 | $ | 17,674,903 | |||
MAXSMAKING INC. | |||||||||||
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME | |||||||||||
FOR THE FISCAL YEARS ENDED | |||||||||||
IN U.S. DOLLARS, EXCEPT SHARE DATA | |||||||||||
For The Fiscal Years Ended | |||||||||||
2025 | 2024 | 2023 | |||||||||
Revenues | $ | 29,220,846 | $ | 21,434,100 | $ | 26,260,268 | |||||
Cost of revenues | (26,605,003) | (17,463,856) | (22,048,972) | ||||||||
Gross profit | 2,615,843 | 3,970,244 | 4,211,296 | ||||||||
Operating expenses: | |||||||||||
Sales and marketing expenses | (462,285) | (606,352) | (490,221) | ||||||||
General and administrative expenses | (1,399,356) | (600,660) | (571,407) | ||||||||
Research and development expenses | (650,629) | (559,048) | (740,800) | ||||||||
Total operating expenses | (2,512,270) | (1,766,060) | (1,802,428) | ||||||||
Income from operations | 103,573 | 2,204,184 | 2,408,868 | ||||||||
Other (expenses) income, net | |||||||||||
Interest expenses | (159,166) | (151,335) | (69,572) | ||||||||
Interest income | 223 | 548 | 1,158 | ||||||||
Other income | 85,113 | 95,767 | 87,399 | ||||||||
Exchange gain (loss) | 72,406 | 17,344 | (2,106) | ||||||||
Other expenses | (16,593) | (16,839) | (140,029) | ||||||||
Income before income tax provision | 85,556 | 2,149,669 | 2,285,718 | ||||||||
Income tax expense | (67,434) | (269,003) | (307,441) | ||||||||
Net income | $ | 18,122 | $ | 1,880,666 | $ | 1,978,277 | |||||
Less: Net income attributable to non-controlling interest | 16,096 | 67,496 | 69,006 | ||||||||
Net income attributable to MaxsMaking Inc. | 2,026 | 1,813,170 | 1,909,271 | ||||||||
Other comprehensive income | |||||||||||
Foreign currency translation adjustment | 52,666 | 36,714 | (39,443) | ||||||||
Comprehensive income | $ | 70,788 | $ | 1,917,380 | $ | 1,938,834 | |||||
Less: comprehensive income (loss) attributable to non- | 832 | (839) | (7,775) | ||||||||
Comprehensive (loss) income attributable to | $ | 69,956 | $ | 1,918,219 | $ | 1,946,609 | |||||
Weighted Average A Shares Outstanding – Basic and | 8,092,857 | 7,575,000 | 7,575,000 | ||||||||
Weighted Average B Shares Outstanding – Basic and | 7,425,000 | 7,425,000 | 7,425,000 | ||||||||
Earnings per A Share – basic and diluted | $ | 0.00 | $ | 0.25 | $ | 0.26 | |||||
Earnings per B Share – basic and diluted | $ | 0.00 | $ | 0.25 | $ | 0.27 | |||||
MAXSMAKING INC. | |||||||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||
FOR THE FISCAL YEARS ENDED | |||||||||||
IN U.S. DOLLARS, EXCEPT SHARE DATA | |||||||||||
For The Fiscal Years Ended | |||||||||||
2025 | 2024 | 2023 | |||||||||
Cash Flows from Operating Activities: | |||||||||||
Net income | $ | 18,122 | $ | 1,880,666 | $ | 1,978,277 | |||||
Adjustments to reconcile net income to net cash provided by | |||||||||||
Depreciation of plant and equipment | 30,573 | 28,548 | 22,638 | ||||||||
Allowance (Reversal of allowance) for expected credit loss | 173,564 | 17,064 | (23,422) | ||||||||
Amortization of right-of-use assets | 138,080 | 179,858 | 189,311 | ||||||||
Amortization of intangible assets | 1,014 | 1,021 | 1,032 | ||||||||
Accounts receivable | (3,791,371) | 168,688 | 1,895,868 | ||||||||
Inventories | (3,817,383) | (412,235) | 56,562 | ||||||||
Other receivables and other current assets | 2,240,000 | (4,142,973) | (1,397,468) | ||||||||
Amount due from related party | (36,433) | 422 | (426) | ||||||||
Deferred tax assets | (41,284) | (19,841) | (2,575) | ||||||||
Operating lease-right of use assets | (122,830) | (45,928) | — | ||||||||
Deferred offering cost | (332,851) | (905,452) | (273,346) | ||||||||
Other non-current assets | — | 196,834 | 178,786 | ||||||||
Accounts payable | 1,091,381 | 1,094,933 | (4,279,114) | ||||||||
Income tax payable | 87,446 | 283,245 | 87,502 | ||||||||
Contract liability | 134,680 | (328,693) | 164,529 | ||||||||
Other payables and accrued liabilities | (928,045) | 13,537 | (100,599) | ||||||||
Lease liabilities | 22,604 | (327,396) | (167,614) | ||||||||
Amount due to related party | (153,012) | (720,729) | 1,070,112 | ||||||||
Net cash used in operating activities | (5,285,745) | (3,038,431) | (599,947) | ||||||||
Cash Flows from Investing Activities: | |||||||||||
Purchases of plant and equipment | (56,877) | (18,514) | (73,646) | ||||||||
Collection from loans to third parties | — | — | 810,250 | ||||||||
Net cash (used in)generated by investing activities | (56,877) | (18,514) | 736,604 | ||||||||
Cash Flows from Financing Activities: | |||||||||||
Proceeds from issuance of ordinary shares upon the | 5,594,926 | — | — | ||||||||
Capital contributions | — | 787,266 | — | ||||||||
Proceeds from third party loans | 184,559 | 260,101 | 71,055 | ||||||||
Proceeds from bank borrowings | 3,036,036 | 4,611,529 | 1,406,889 | ||||||||
Repayments of third party loans | (325,058) | (745,156) | — | ||||||||
Repayment of bank borrowings | (3,191,570) | (1,813,680) | (1,806,122) | ||||||||
Net cash provided by(used in) financing activities | 5,298,893 | 3,100,060 | (328,178) | ||||||||
Effect of Exchange Rate Changes on Cash | (10,126) | 971 | 3,715 | ||||||||
Net (Decrease) Increase in cash | (53,855) | 44,086 | (187,806) | ||||||||
Cash, Beginning of Year | 176,236 | 132,150 | 319,956 | ||||||||
Cash, End of Year | 122,381 | $ | 176,236 | $ | 132,150 | ||||||
Supplemental disclosure of cash flow information: | |||||||||||
Cash paid for income tax | 21,273 | $ | 5,598 | $ | 222,026 | ||||||
Cash paid for interest | 155,572 | $ | 151,335 | $ | 69,572 | ||||||
Supplemental disclosure of cash flow information: | |||||||||||
Right-of-use assets obtained in exchange for operating lease | 177,415 | $ | 66,419 | $ | 18,639 | ||||||
View original content:https://www.prnewswire.com/news-releases/maxsmaking-inc-reports-fiscal-year-2025-financial-results-302703823.html
SOURCE MaxsMaking Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer
- FDA clears Merck's Keytruda combo for muscle-invasive bladder cancer
- Mercator Acquisition Corp. raises $172.5M in Nasdaq IPO
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Layoffs, Earnings, Definitive Agreement, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share